what are glp-1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment GLP-1 Agonists - What is
Description
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
Early PsA may display nonspecific musculoskeletal symptoms, such as inflammatory arthralgia or morning stiffness, even in the absence of overt synovitis or radiographic erosions (12)
Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial
Always consult your GP or pharmacist before starting any supplement, particularly if you take prescribed medications for diabetes or other conditions
[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, et al
